Association between hypogonadism and severity of chronic obstructive pulmonary disease: A cross-sectional study

被引:0
作者
Castro, Horacio Matias [1 ]
Furcada, Joaquin Maritano [1 ]
De Vito, Eduardo Luis [2 ]
Suarez, Sebastian Matias [3 ]
Knoblovits, Pablo [3 ]
Costanzo, Pablo Rene [3 ]
机构
[1] Hosp Italiano Buenos Aires, Pulmonol Dept, Buenos Aires, Argentina
[2] Univ Buenos Aires, Inst Med Res Alfredo Lanari, Fac Med, Buenos Aires, Argentina
[3] Hosp Italiano Buenos Aires, Endocrinol Metab & Nucl Med Serv, Androl Sect, Buenos Aires, Argentina
来源
MEDICINA CLINICA | 2025年 / 164卷 / 03期
关键词
Hypogonadism; Chronic obstructive pulmonary disease; Testosterone; Hormones; Disease severity index; Comorbidity; SERUM TESTOSTERONE; MEN; COPD; PREVALENCE; WEAKNESS; HEALTH; AGE;
D O I
10.1016/j.medcli.2024.08.016
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Introduction and objectives: Chronic obstructive pulmonary disease (COPD) frequently coexists with other comorbidities, including hypogonadism. However, the association between COPD severity and hypogonadism remains controversial. This study aimed to evaluate this association and compare the clinical characteristics of hypogonadal and eugonadal COPD patients. Materials and methods: A cross-sectional study including men with stable COPD was performed. Hypogonadism was diagnosed based on the presence of symptoms, according to the Androgen Deficiency in Aging Males questionnaire, and a total testosterone deficit (<300 ng/dL). COPD severity was classified according to the Spanish COPD guideline risk classification. A multivariate logistic regression analysis was performed in order to evaluate the relationship between COPD severity and hypogonadism. Results: 134 subjects were recruited. The prevalence of hypogonadism was higher in severe COPD than in mild COPD, with a prevalence ratio of 1.8 (p = 0.007). An increased odds of hypogonadism was observed in severe COPD subjects (OR 2.60, 95% CI 1.23-5.48, p = 0.012) independent of age, body mass index, cardiovascular disease, and chronic renal failure. Hypogonadal COPD patients exhibited lower percentage levels of FVC and FEV1 and a higher degree of dyspnea than compared to eugonadal COPD patients. Conclusion: Patients with severe COPD had a higher prevalence of hypogonadism compared to those with mild COPD. Additionally, severe COPD was identified as an independent risk factor for hypogonadism. These findings suggest that hypogonadism should be evaluated in patients with COPD, particularly in those with severe disease. (c) 2024 Elsevier Espana, S.L.U. All rights are reserved, including those for text and data mining, AI training, and similar technologies.
引用
收藏
页码:109 / 116
页数:8
相关论文
共 43 条
[1]   Testosterone replacement therapy and hospitalization rates in men with COPD [J].
Baillargeon, Jacques ;
Urban, Randall James ;
Zhang, Wei ;
Zaiden, Mohammed Fathi ;
Javed, Zulqarnain ;
Sheffield-Moore, Melinda ;
Kuo, Yong-Fang ;
Sharma, Gulshan .
CHRONIC RESPIRATORY DISEASE, 2018, 16
[2]   Hypogonadism in chronic obstructive pulmonary disease: incidence and effects [J].
Balasubramanian, Vijay ;
Naing, Soe .
CURRENT OPINION IN PULMONARY MEDICINE, 2012, 18 (02) :112-117
[3]   Testosterone Therapy in Men With Hypogonadism: An Endocrine Society* Clinical Practice Guideline [J].
Bhasin, Shalender ;
Brito, Juan P. ;
Cunningham, Glenn R. ;
Hayes, Frances J. ;
Hodis, Howard N. ;
Matsumoto, Alvin M. ;
Snyder, Peter J. ;
Swerdloff, Ronald S. ;
Wu, Frederick C. ;
Yialamas, Maria A. .
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 2018, 103 (05) :1715-1744
[4]   Intraindividual variation in levels of serum testosterone and other reproductive and adrenal hormones in men [J].
Brambilla, Donald J. ;
O'Donnell, Amy B. ;
Matsumoto, Alvin M. ;
McKinlay, John B. .
CLINICAL ENDOCRINOLOGY, 2007, 67 (06) :853-862
[5]   The body-mass index, airflow obstruction, dyspnea, and exercise capacity index in chronic obstructive pulmonary disease [J].
Celli, BR ;
Cote, CG ;
Marin, JM ;
Casanova, C ;
de Oca, MM ;
Mendez, RA ;
Pinto Plata, V ;
Cabral, HJ .
NEW ENGLAND JOURNAL OF MEDICINE, 2004, 350 (10) :1005-1012
[6]   European Academy of Andrology (EAA) guidelines* on investigation, treatment and monitoring of functional hypogonadism in males [J].
Corona, Giovanni ;
Goulis, Dimitrios G. ;
Huhtaniemi, Ilpo ;
Zitzmann, Michael ;
Toppari, Jorma ;
Forti, Gianni ;
Vanderschueren, Dirk ;
Wu, Frederick C. .
ANDROLOGY, 2020, 8 (05) :970-987
[7]   ATS statement: Guidelines for the six-minute walk test [J].
Crapo, RO ;
Casaburi, R ;
Coates, AL ;
Enright, PL ;
MacIntyre, NR ;
McKay, RT ;
Johnson, D ;
Wanger, JS ;
Zeballos, RJ ;
Bittner, V ;
Mottram, C .
AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2002, 166 (01) :111-117
[8]   Hypogonadism in patients with chronic obstructive pulmonary disease: relationship with airflow limitation, muscle weakness and systemic inflammation [J].
Daabis, Rasha Galal ;
Rehem, Rania Naguib Abdel ;
Hassan, Marwa Mohamed ;
Khalil, Gihane Ibrahim .
ALEXANDRIA JOURNAL OF MEDICINE, 2016, 52 (01) :27-33
[9]   Catabolic/anabolic balance and muscle wasting in patients with COPD [J].
Debigaré, R ;
Marquis, K ;
Côté, CH ;
Tremblay, RR ;
Michaud, A ;
LeBlanc, P ;
Maltais, F .
CHEST, 2003, 124 (01) :83-89
[10]   Testosterone, Hypogonadism, and Heart Failure [J].
Di Lodovico, Elena ;
Facondo, Paolo ;
Delbarba, Andrea ;
Pezzaioli, Letizia Chiara ;
Maffezzoni, Filippo ;
Cappelli, Carlo ;
Ferlin, Alberto .
CIRCULATION-HEART FAILURE, 2022, 15 (07) :E008755